These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1054 related articles for article (PubMed ID: 29768063)

  • 41. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
    Chen S; Lin X; He R; Zhang W; Kang M; Xu R
    Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
    Chen L; Wang L; Qin J; Wei DS
    Life Sci; 2020 Dec; 262():118477. PubMed ID: 32971103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
    Zheng Q; Diao S; Wang Q; Zhu C; Sun X; Yin B; Zhang X; Meng X; Wang B
    J Cell Mol Med; 2019 Jan; 23(1):357-369. PubMed ID: 30353649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.
    Wang Y; Sakaguchi M; Sabit H; Tamai S; Ichinose T; Tanaka S; Kinoshita M; Uchida Y; Ohtsuki S; Nakada M
    J Neurosurg; 2023 Mar; 138(3):639-648. PubMed ID: 35932265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
    Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
    J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer.
    Zheng YZ; Liang L
    Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
    Guo Y; He X; Zhang M; Qu Y; Gu C; Ren M; Wang H; Ning W; Li J; Yu C; Zhang H
    J Neurooncol; 2020 Apr; 147(2):327-337. PubMed ID: 32170633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
    Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
    Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
    Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
    Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MircoRNA-129-5p suppresses the development of glioma by targeting HOXC10.
    Liu J; Cheng C; Jiao J; Huang W; Huang J; Sun J; Shao J
    Pathol Res Pract; 2020 Apr; 216(4):152868. PubMed ID: 32111444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway.
    Zhang H; Zhang L; Lu M
    Bioengineered; 2021 Dec; 12(2):11909-11921. PubMed ID: 34802381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.